Guangdong Taienkang Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 760.07 million compared to CNY 782.8 million a year ago. Revenue was CNY 760.79 million compared to CNY 783.48 million a year ago.

Net income was CNY 160.2 million compared to CNY 174.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.44 a year ago. Diluted earnings per share from continuing operations was CNY 0.38 compared to CNY 0.44 a year ago.